Psy87 - Economic Burden of Transthyretin Familial Amyloid Polyneuropathy

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2662
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Transthyretin-Associated Familial Amyloid Polyneuropathy - Current and Emerging Therapies

European Neurological Review
Neurology
2012English

Transthyretin Glu18, a New Variant Associated With Familial Amyloid Polyneuropathy

Journal of the University of Malaya Medical Centre
Medicine
1998English

Transthyretin Familial Amyloid Polyneuropathy Impact on Health-Related Quality of Life

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Positive Real-World Effectiveness of Tafamidis for Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area

Journal of Neuromuscular Diseases
Neurology
2015English

Noninvasive Cardiovascular Findings in Familial Amyloid Polyneuropathy.

Heart
Cardiovascular MedicineCardiology
1978English

Therapeutic Strategy for Familial Amyloid Polyneuropathy (FAP)

Clinical Neurology
Neurology
2009English

Familial Amyloidotic Polyneuropathy Without Familial Occurrence: Carrier Detection by the Radioimmunoassay of Variant Transthyretin.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1988English

Recent Advances in the Treatment of Familial Amyloid Polyneuropathy

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy